Showing 761 - 780 results of 26,842 for search '(( 50 ((ppm decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (we decrease)) ))', query time: 0.79s Refine Results
  1. 761

    Fig 1 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  2. 762

    Table1_Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.DOCX by Michael Horckmans (14206388)

    Published 2022
    “…The relevance of these data has, however, not been explored to date in humans. In a population study comprising 50 patients with coronary artery disease (CAD) and 50 age-matched control individuals, we analyzed P2RY4 mutations and their potential association with CAD severity and fasting plasma parameters. …”
  3. 763
  4. 764

    Fig 2 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  5. 765

    Fig 14 - by B. Ulfhake (6293984)

    Published 2022
    Subjects:
  6. 766
  7. 767
  8. 768
  9. 769
  10. 770
  11. 771
  12. 772
  13. 773

    Presentation_1_Design of Efficient Exciplex Emitters by Decreasing the Energy Gap Between the Local Excited Triplet (3LE) State of the Acceptor and the Charge Transfer (CT) States... by Xiaofang Wei (546822)

    Published 2019
    “…Finally, the Φ<sub>PL</sub> of TAPC:TX-TerPy (7:1) and TCTA:TX-TerPy (7:1) are 65.2 and 69.6%. When we changed the doping concentration of the exciplex from 15% to 50%, the ratio of the triplet decreased, and Φ<sub>PL</sub> decreased by half, perhaps due to the increased energy gap between <sup>1</sup>CT and <sup>3</sup>LE. …”
  14. 774

    Presentation_1_Design of Efficient Exciplex Emitters by Decreasing the Energy Gap Between the Local Excited Triplet (3LE) State of the Acceptor and the Charge Transfer (CT) States... by Xiaofang Wei (546822)

    Published 2019
    “…Finally, the Φ<sub>PL</sub> of TAPC:TX-TerPy (7:1) and TCTA:TX-TerPy (7:1) are 65.2 and 69.6%. When we changed the doping concentration of the exciplex from 15% to 50%, the ratio of the triplet decreased, and Φ<sub>PL</sub> decreased by half, perhaps due to the increased energy gap between <sup>1</sup>CT and <sup>3</sup>LE. …”
  15. 775
  16. 776

    Initial treatment regimen. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  17. 777

    Patients baseline characteristics. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  18. 778

    Overall survival. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  19. 779

    Progression-free survival by treatment. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  20. 780

    Maintenance regimen and adverse event management. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”